• $7,357.00
    Market Cap
  • -95.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
1.1M
-25.27%
1.5M
+70.21%
884,704
N/A
Research and Development Expense
-623,964
-45.70%
-1.1M
+40.24%
-819,403
N/A
Depreciation and Amortization Expense
839
-26.92%
1,148
-27.06%
1,574
N/A
Total Operating Expenses
1.1M
-25.27%
1.5M
+70.21%
884,704
N/A
Operating Profit
-1.4M
-39.36%
-2.3M
+70.42%
-1.4M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-2,105
N/A
Interest Income and Expense and Net
0
N/A
0
+100.00%
-2,105
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
2,105
N/A
Income before Taxes
-743,228
-81.75%
-4.1M
+157.76%
-1.6M
N/A
Income Taxes
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-743,228
-81.75%
-4.1M
+157.76%
-1.6M
N/A
Net Income from Continuing Operations Applicable to Common
-743,228
-81.75%
-4.1M
+157.76%
-1.6M
N/A
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
-0.02
-84.62%
-0.13
N/A
N/A
N/A
Basic Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
Diluted Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
413,025
+86.73%
221,188
+543.68%
34,363
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
413,025
+86.73%
221,188
+543.68%
34,363
N/A
Total Current Assets
635,677
+61.73%
393,042
+111.67%
185,690
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
2,438
-25.60%
3,277
-25.94%
4,425
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
798,218
+34.88%
591,794
+40.58%
420,962
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.1M
+23.84%
1.7M
-25.25%
2.2M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
6.7M
-9.69%
7.4M
+35.61%
5.5M
N/A
Retained Earnings
-43.0M
+1.76%
-42.2M
+10.67%
-38.2M
N/A
Total Stockholders Equity
-5.9M
-13.55%
-6.8M
+35.19%
-5.1M
N/A
Total Shares Outstanding
47.6M
+36.15%
35.0M
+16.72%
30.0M
N/A
Cash Flow
Cash from Operating Activities
-1.4M
-43.93%
-2.5M
+228.52%
-765,206
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
0
N/A
0
-100.00%
11,500
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.6M
-40.71%
2.7M
+253.43%
764,139
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-106.94%
-86.71%
-804.40%
+135.79%
-341.16%
N/A
Return on Equity
11.65%
-82.98%
68.44%
+105.43%
33.31%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.31
+30.62%
0.23
+183.23%
0.08
N/A
Cash Ratio
0.20
+50.76%
0.13
+764.05%
0.02
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow